Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 156 entries
View as:

Acquired Immunodeficiency in ANCA Associated Vasculitis

Phase: N/A Priority: Normal
NCT ID: NCT03514979 Org: User:
Start: 06/30/18 End: 01/31/21 Due: 01/31/22

Detection Rate of Atrial Fibrillation in Patients Implanted With ILRs

Phase: N/A Priority: Normal
NCT ID: NCT02843516 Org: User:
Start: 03/31/09 End: 06/30/16 Due: 06/30/17

mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R)

Phase: N/A Priority: Normal
NCT ID: NCT04390464 Org: User:
Start: 05/08/20 End: 05/01/22 Due: 05/01/23

Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT00539799 Org: User:
Start: - End: - Due: -

Trial Comparing the Incidence of Steal Syndrome in the Two Types of anTEcubitaL Fossa Arteriovenous fistuLa AVF

Phase: N/A Priority: Normal
NCT ID: NCT02297451 Org: User:
Start: 02/28/11 End: 12/31/18 Due: 12/31/19

Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis

Phase: N/A Priority: Normal
NCT ID: NCT00414128 Org: User:
Start: 03/31/07 End: 02/28/13 Due: 02/28/14

mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms

Phase: N/A Priority: Normal
NCT ID: NCT04393246 Org: User:
Start: 07/03/20 End: 06/08/22 Due: 06/08/23

Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY

Phase: N/A Priority: Normal
NCT ID: NCT04241601 Org: User:
Start: 08/05/20 End: 01/25/23 Due: 01/25/24

INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03273972 Org: User:
Start: 09/07/17 End: 10/10/18 Due: 10/10/19

Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2

Phase: N/A Priority: Normal
NCT ID: NCT01827735 Org: User:
Start: 03/31/13 End: 05/31/14 Due: 05/31/15

Remote Evaluation of the Naída CI M90 (Marvel) Sound Processor

Phase: N/A Priority: Normal
NCT ID: NCT05007886 Org: User:
Start: 08/13/21 End: 08/01/23 Due: 08/01/24

Hearing Handicap in Patients With Single Sided Deafness

Phase: N/A Priority: Normal
NCT ID: NCT02525640 Org: User:
Start: 08/01/15 End: 02/01/17 Due: 02/01/18

Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care

Phase: N/A Priority: Normal
NCT ID: NCT04589936 Org: User:
Start: 09/03/20 End: 06/30/21 Due: 06/30/22

Study of Tolerance to Oral Peanut

Phase: N/A Priority: Normal
NCT ID: NCT01259804 Org: User:
Start: 01/31/08 End: 01/31/12 Due: 01/31/13

Prevalence of Musculoskeletal Symptoms in the Cambridge NIHR BioResource

Phase: N/A Priority: Normal
NCT ID: NCT04632563 Org: User:
Start: 11/30/20 End: 08/31/21 Due: 08/31/22

Feasibility of Additional Physiotherapy for Patients Aged 75 and Older

Phase: N/A Priority: Normal
NCT ID: NCT04144634 Org: User:
Start: 10/29/19 End: 04/01/20 Due: 04/01/21

Plasma Exchange for Renal Vasculitis

Phase: N/A Priority: Normal
NCT ID: NCT01408836 Org: User:
Start: 03/31/95 End: 12/31/03 Due: 12/31/04

Computerised Therapy in Chronic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01928602 Org: User:
Start: 11/30/13 End: 02/29/16 Due: 02/28/17

The Use of a Handheld Fan to Manage Breathlessness - A Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT00974558 Org: User:
Start: 01/31/10 End: 09/30/11 Due: 09/30/12

Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease

Phase: N/A Priority: Normal
NCT ID: NCT03355027 Org: User:
Start: 11/30/17 End: 11/30/23 Due: 11/30/24

Metabolic Consequences of Gastrointestinal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02836353 Org: User:
Start: 01/31/17 End: 03/11/19 Due: 03/11/20

Skin Sodium and Salt Sensitivity of Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT05976438 Org: User:
Start: 08/31/23 End: 12/31/24 Due: 12/31/25

The Feasibility of Drug Delivery to Infants During Breastfeeding

Phase: N/A Priority: Normal
NCT ID: NCT03799367 Org: User:
Start: 07/09/18 End: 12/31/18 Due: 12/31/19

A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03306472 Org: User:
Start: 07/20/17 End: 10/31/23 Due: 10/31/24

A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems

Phase: N/A Priority: Normal
NCT ID: NCT03098680 Org: User:
Start: 04/24/17 End: 02/29/20 Due: 02/28/21